"Homogenized Milk and Atherosclerosis" - Sunflower Publishing (Sweden) Publishes Bestseller in eBook Format

Researcher Nicholas Sampsidis, protege of cardiologist Kurt A. Oster, M.D. and Fairfield University professor Donald J. Ross, Ph.D., concludes in two, new eBook titles that chronic illnesses may be prevented and even reversed by regulating two, key enzymes at the center of inflammation.

Aneby, Sweden, September 19, 2011 --(PR.com)-- Some 30 years ago, researcher Nicholas Sampsidis stumbled upon a gold nugget after taking his first step as a medical author. The information became the title: "Homogenized Milk & Atherosclerosis." Nearly, 1 million copies were printed (1).

Theory that was so contrarian, back then, has become Wikipedia mainstream, today. The subject is XO, an enzyme in dairy that clogs arteries as fast as it's now clogging servers. It's not cholesterol. Just tapping in "xanthine oxidase" (XO) into a search engine gives a decibel appreciation for the laboratory buzz.

The info rush about XO is tied to a rather, mind-opening discovery.

It turns out that XO is responsible for much more than just triggering heart disease.

Researchers in dozens of countries have largely confirmed the veracity of the original thesis of cardiologist, K.A. Oster, M.D., and Fairfield University professor, Donald J. Ross, Ph.D., about XO triggering gout, diabetes, non-healing wounds, chest pain, psoriasis, and multiple sclerosis (2,3). In fact, XO is now thought to be behind more than 50 chronic degenerative diseases(4).

While researchers continue to debate whether XO originates from homogenized cow's milk, in which it's plentiful, or from the human liver, Nicholas Sampsidis argues that both sources might be involved. “However, cow's milk XO is roughly 15 times more potent,” he says, “the tipping point factor in overcoming the body's anti-radical defenses and forming lesions. Cow's milk XO is hard liquor; human XO is 2.8% beer.”(5)

Alzheimer's, arthritis and heart disease are the same disease - that is, they are at the very start. They all start with inflammation as elucidated in the Time magazine cover story of Feb. 23, 2004 and in the ABC World News story (John McKenzie, Jan. 14, 2004) (6).

“But things only start to get interesting during the inflammatory process,” according to Sampsidis. “XO is smack in the middle of the action, torching the fat component of cell membranes and raising havoc.”

“The problem is that tissues don't burn cleanly. A smoky fire churns out free radical byproducts. Cigarette smoke and sunlight also produce free radicals but nowhere near as many as XO (7). A chain reaction of cellular death ensues. When lesions outpace healing, oxidative stress to a tissue interferes with function (8). A diagnosis is then made - diabetes, rheumatism, Lupus and so forth.

“The name of the disease depends, simply enough, where XO nests up.”

The Nobel laureate good news is that because of the common disease pathway, each condition is amenable to nearly the same treatment. It consists of nutritional guidelines for inhibiting XO - the ORS Method.

Backed by 250 references, the twin, eBook titles, "Homogenized Milk & Atherosclerosis - Healing Heart Disease from A to XO," and, "Something Called XO," emphasize that taking charge of one’s health requires avoiding foods containing XO and inhibiting renegade XO that is already in one’s system.

Sampsidis notes: “Oster and Ross are finally being revisited. The XO link to so many diseases is the mother lode of health breakthroughs - the ORS Method the penicillin of chronic illnesses.” http://healthsunflowerpublishing.com.

1. Homogenized Milk & Atherosclerosis, Copyright © 1980, 1983, N. Sampsidis (First Editions) Sunflower Publishing Co., New York, ISBN 0-943550-00-9 Book format.

2. “Is an Enzyme in Homogenized Milk the Culprit in Dietary-induced Atherosclerosis,” Medical Counterpoint, K.A. Oster, 5:26-36, Nov 1973.

3. Homogenized Milk May Cause Your Heart Attack: the XO Factor, Oster, Ross, Dawkins, Park City Press, 1983, pp. 77, 264.

4. “Elevated Levels of Xanthine Oxidase in Serum of Patients with Inflammatory and Autoimmune Rheumatic Diseases,” Inflammation, R. Miesel, M. Zuber, 17(5):551-61, Oct. 1993.

5. “Molecular Characterization of Human Xanthine Oxidoreductase: The Enzyme is Grossly Deficient in Molybdenum and Substantially Deficient in Iron-sulphur Centres,” Jour. Biochem, B.L. Godber, G. Schwarz, R.R. Mendel,D.J. Lowe, R.C. Bray, R. Eisenthal, R. Harrison, June 1, 2005, 1;388 (Pt 2):501-8.

6. “Link between Alzheimer’s, Heart Disease,” ABC World News Diane Sawyer, John McKenzie, Jan. 14, 2004.

7. “Modulation of Radiation-Induced Changes in the Xanthine Oxidoreductase System in the Livers of Mice by its Inhibitors,” Radiation Research, M. Srivastava, D. Chandra, R.K. Kale, 157(3):290-297; 2002.

8. “Free Radicals: their History and Current Status in Aging and Disease,” Ann Clin Lab Sci, J.A. Knight, 28(6):331-46, Nov-Dec 1998.

Sunflower Publishing Company
Nicholas Sampsidis
+46 7 631 09 335